The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies

Tendinopathies encompass a highly prevalent, multi-faceted spectrum of disorders, characterized by activity-related pain, compromised function, and propensity for an extended absence from sport and the workplace. The pathophysiology of tendinopathy continues to evolve. For decades, it has been related primarily to repetitive overload trauma but more recently, the onset of tendinopathy has been attributed to the tissue’s failed attempt to heal after subclinical inflammatory and immune challenges (failed healing model). Conventional tendinopathy management produces only short-term symptomatic relief and often results in incomplete repair or healing leading to compromised tendon function. For this reason, there has been increased effort to develop therapeutics to overcome the tissue’s failed healing response by targeting the cellular metaplasia and pro-inflammatory extra-cellular environment. On this basis, stem cell-based therapies have been proposed as an alternative therapeutic approach designed to modify the course of the various tendon pathologies. Mesenchymal stem/stromal cells (MSCs) are multipotent stem cells often referred to as “medicinal signaling cells” due to their immunomodulatory and anti-inflammatory properties that can produce a pro-regenerative microenvironment in pathological tendons. However, the adoption of MSCs into clinical practice has been limited by FDA regulations and perceived risk of adverse events upon infusion in vivo. The introduction of cell-free approaches, such as the extracellular vesicles of MSCs, has encouraged new perspectives for the treatment of tendinopathies, showing promising short-term results. In this article, we review the most recent advances in MSC-based and MSC-derived therapies for tendinopathies. Preclinical and clinical studies are included with comment on future directions of this rapidly developing therapeutic modality, including the importance of understanding tissue loading and its relationship to any treatment regimen.

[1]  Jinqiu Zhang,et al.  Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? , 2022, Cell Death & Disease.

[2]  A. Mauro,et al.  Tendon Healing Response Is Dependent on Epithelial–Mesenchymal–Tendon Transition State of Amniotic Epithelial Stem Cells , 2022, Biomedicines.

[3]  G. Prencipe,et al.  Tendon Immune Regeneration: Insights on the Synergetic Role of Stem and Immune Cells during Tendon Regeneration , 2022, Cells.

[4]  O. Parolini,et al.  Editorial: MSC-Derived Extracellular Vesicles and Secreted Factors as “Cell-Free” Therapeutic Alternatives in Regenerative Medicine , 2022, Frontiers in Bioengineering and Biotechnology.

[5]  T. Best,et al.  Human Tendon Stem/Progenitor Cell Features and Functionality Are Highly Influenced by in vitro Culture Conditions , 2021, Frontiers in Bioengineering and Biotechnology.

[6]  Yongxiang Fang,et al.  CD146 Delineates an Interfascicular Cell Sub-Population in Tendon That Is Recruited during Injury through Its Ligand Laminin-α4 , 2021, International journal of molecular sciences.

[7]  Y. Pathak,et al.  A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine , 2021, Journal of translational medicine.

[8]  Yaohua He,et al.  Adipose Stem Cell–Derived Exosomes Ameliorate Chronic Rotator Cuff Tendinopathy by Regulating Macrophage Polarization: From a Mouse Model to a Study in Human Tissue , 2021, The American journal of sports medicine.

[9]  M. Fredericson,et al.  Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial , 2021, PloS one.

[10]  O. Parolini,et al.  Amniotic membrane‐mesenchymal stromal cells secreted factors and extracellular vesicle‐miRNAs: Anti‐inflammatory and regenerative features for musculoskeletal tissues , 2021, Stem cells translational medicine.

[11]  K. Chamari,et al.  Promising improvement of chronic lateral elbow tendinopathy by using adipose derived mesenchymal stromal cells: a pilot study , 2021, Journal of Experimental Orthopaedics.

[12]  L. Galatz,et al.  Tendinopathy , 2021, Nature Reviews Disease Primers.

[13]  C. Fan,et al.  Extracellular vesicles from hydroxycamptothecin primed umbilical cord stem cells enhance anti-adhesion potential for treatment of tendon injury , 2020, Stem cell research & therapy.

[14]  Zhaozhu Li,et al.  Tendon stem cell-derived exosomes regulate inflammation and promote the high-quality healing of injured tendon , 2020, Stem cell research & therapy.

[15]  N. Maffulli,et al.  In Vitro Innovation of Tendon Tissue Engineering Strategies , 2020, International journal of molecular sciences.

[16]  P. Lui Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Promotion of Tendon Repair - an Update of Literature , 2020, Stem Cell Reviews and Reports.

[17]  T. Best,et al.  Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells. , 2020, Cytotherapy.

[18]  A. Agarwal,et al.  Signature quality attributes of CD146+ mesenchymal stem/stromal cells correlate with high therapeutic and secretory potency , 2020, Stem cells.

[19]  S. Rhatomy,et al.  Prospect of stem cells conditioned medium (secretome) in ligament and tendon healing: A systematic review , 2020, Stem cells translational medicine.

[20]  Wei Song,et al.  Adipose Stem Cell–Derived Exosomes Decrease Fatty Infiltration and Enhance Rotator Cuff Healing in a Rabbit Model of Chronic Tears , 2020, The American journal of sports medicine.

[21]  A. James,et al.  Five Decades Later, Are Mesenchymal Stem Cells Still Relevant? , 2020, Frontiers in Bioengineering and Biotechnology.

[22]  Xin Fu,et al.  Bone marrow mesenchymal stem cells-derived exosomes promote tendon regeneration via facilitating the proliferation and migration of endogenous tendon stem/progenitor cells. , 2020, Acta biomaterialia.

[23]  F. Guilak,et al.  Stem cell‐derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  T. Best,et al.  Infrapatellar fat pad-derived MSC response to inflammation and fibrosis induces an immunomodulatory phenotype involving CD10-mediated Substance P degradation , 2019, Scientific Reports.

[25]  Xingwang Liu,et al.  Stem Cell–Conditioned Medium Promotes Graft Remodeling of Midsubstance and Intratunnel Incorporation After Anterior Cruciate Ligament Reconstruction in a Rat Model , 2019, The American journal of sports medicine.

[26]  Dapeng Jiang,et al.  Extracellular vesicles from bone marrow-derived multipotent mesenchymal stromal cells regulate inflammation and enhance tendon healing , 2019, Journal of Translational Medicine.

[27]  Xia Kang,et al.  Exosomes from tendon stem cells promote injury tendon healing through balancing synthesis and degradation of the tendon extracellular matrix , 2019, Journal of cellular and molecular medicine.

[28]  R. Misra,et al.  The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. , 2019, Cytokine & growth factor reviews.

[29]  E. Jones,et al.  Mesenchymal Stem Cell Functionalization for Enhanced Therapeutic Applications. , 2019, Tissue engineering. Part B, Reviews.

[30]  J. Burk Mechanisms of Action of Multipotent Mesenchymal Stromal Cells in Tendon Disease , 2019, Tendons.

[31]  J. Gimble,et al.  The cell secretome in personalized and regenerative medicine. , 2018, Biochimie.

[32]  Shiyi Chen,et al.  Bone Marrow Stem Cells‐Seeded Polyethylene Terephthalate Scaffold in Repair and Regeneration of Rabbit Achilles Tendon , 2018, Artificial organs.

[33]  Y. Moon,et al.  Therapeutic Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cells Combined with Polydeoxyribonucleotides on Full-Thickness Rotator Cuff Tendon Tear in a Rabbit Model , 2018, Cell transplantation.

[34]  B. de Campos Vidal,et al.  Injured Achilles Tendons Treated with Adipose-Derived Stem Cells Transplantation and GDF-5 , 2018, Cells.

[35]  Younan Xia,et al.  The effect of adipose-derived stem cell sheets and CTGF on early flexor tendon healing in a canine model , 2018, Scientific Reports.

[36]  G. Rossi,et al.  Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model , 2018, BMC Musculoskeletal Disorders.

[37]  Sohee Oh,et al.  Intratendinous Injection of Autologous Adipose Tissue‐Derived Mesenchymal Stem Cells for the Treatment of Rotator Cuff Disease: A First‐In‐Human Trial , 2018, Stem cells.

[38]  K. Ting,et al.  Tendinopathy: injury, repair, and current exploration , 2018, Drug design, development and therapy.

[39]  L. Arranz,et al.  Nestin-expressing progenitor cells: function, identity and therapeutic implications , 2018, Cellular and Molecular Life Sciences.

[40]  Piul S. Rabbani,et al.  Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion , 2018, PloS one.

[41]  S. J. Kim,et al.  Effects of bone marrow aspirate concentrate and platelet-rich plasma on patients with partial tear of the rotator cuff tendon , 2018, Journal of Orthopaedic Surgery and Research.

[42]  M. Viganò,et al.  Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up , 2018, Knee Surgery, Sports Traumatology, Arthroscopy.

[43]  S. Formisano,et al.  Inflammation in tendinopathy. , 2017, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[44]  R. Perez-Fernandez,et al.  Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine , 2017, International journal of molecular sciences.

[45]  R. van Weeren,et al.  Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial , 2017, Stem Cell Research & Therapy.

[46]  I. de Blas,et al.  Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon. , 2017, Veterinary journal.

[47]  A. Caplan New MSC: MSCs as pericytes are Sentinels and gatekeepers , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[48]  E. Alsberg,et al.  Combined Administration of ASCs and BMP-12 Promotes an M2 Macrophage Phenotype and Enhances Tendon Healing , 2017, Clinical orthopaedics and related research.

[49]  C. Laurencin,et al.  Engineered stem cell niche matrices for rotator cuff tendon regenerative engineering , 2017, PloS one.

[50]  S. Chung,et al.  Therapeutic Mechanisms of Human Adipose-Derived Mesenchymal Stem Cells in a Rat Tendon Injury Model , 2017, The American journal of sports medicine.

[51]  W. Murphy,et al.  Immune modulation with primed mesenchymal stem cells delivered via biodegradable scaffold to repair an Achilles tendon segmental defect , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[52]  G. Murrell,et al.  Inflammatory mechanisms in tendinopathy – towards translation , 2017, Nature Reviews Rheumatology.

[53]  A. Salgado,et al.  Mesenchymal Stem Cell Secretome: A Potential Tool for the Prevention of Muscle Degenerative Changes Associated With Chronic Rotator Cuff Tears , 2017, The American journal of sports medicine.

[54]  H. Ouyang,et al.  Single-cell analysis reveals a nestin+ tendon stem/progenitor cell population with strong tenogenic potentiality , 2016, Science Advances.

[55]  Matthew J. Silva,et al.  The effect of mesenchymal stromal cell sheets on the inflammatory stage of flexor tendon healing , 2016, Stem Cell Research & Therapy.

[56]  A. Avcı,et al.  Comparison of the early period effects of bone marrow-derived mesenchymal stem cells and platelet-rich plasma on the Achilles tendon ruptures in rats , 2016, Connective tissue research.

[57]  E. Rio,et al.  Revisiting the continuum model of tendon pathology: what is its merit in clinical practice and research? , 2016, British Journal of Sports Medicine.

[58]  Rostyslav V Bubnov,et al.  A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions , 2016, International Orthopaedics.

[59]  G. Camussi,et al.  Equine Amniotic Microvesicles and Their Anti-Inflammatory Potential in a Tenocyte Model In Vitro. , 2016, Stem cells and development.

[60]  H. Ouyang,et al.  Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment , 2016, Stem cells.

[61]  Ivan Martin,et al.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.

[62]  Matthew J. Silva,et al.  Effect of adipose‐derived stromal cells and BMP12 on intrasynovial tendon repair: A biomechanical, biochemical, and proteomics study , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[63]  J. Goh,et al.  Bone Marrow Derived Mesenchymal Stem Cell Augmentation of Rabbit Flexor Tendon Healing. , 2015, Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand.

[64]  A. Uccelli,et al.  The immunomodulatory function of mesenchymal stem cells: mode of action and pathways , 2015, Annals of the New York Academy of Sciences.

[65]  Guodong Yang,et al.  Harnessing endogenous stem/progenitor cells for tendon regeneration. , 2015, The Journal of clinical investigation.

[66]  Stasinopoulos Dimitrios Exercise for tendinopathy. , 2015, World journal of methodology.

[67]  Marian F Young,et al.  Tendon Functional Extracellular Matrix , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[68]  C. Crowe,et al.  Optimization of an injectable tendon hydrogel: the effects of platelet-rich plasma and adipose-derived stem cells on tendon healing in vivo. , 2015, Tissue engineering. Part A.

[69]  H. Harn,et al.  Human Adipose-Derived Stem Cells Accelerate the Restoration of Tensile Strength of Tendon and Alleviate the Progression of Rotator Cuff Injury in a Rat Model , 2015, Cell transplantation.

[70]  Martin Majewski,et al.  Biologics for tendon repair , 2014, Advanced drug delivery reviews.

[71]  F. Sarrafzadeh-Rezaei,et al.  Comparative Study on Functional Effects of Allotransplantation of Bone Marrow Stromal Cells and Adipose Derived Stromal Vascular Fraction on Tendon Repair: A Biomechanical Study in Rabbits , 2014, Cell journal.

[72]  G. Thiébat,et al.  In vitro characterization of stem/progenitor cells from semitendinosus and gracilis tendons as a possible new tool for cell-based therapy for tendon disorders. , 2014, Joints.

[73]  W. Liu,et al.  Repair of Achilles tendon defect with autologous ASCs engineered tendon in a rabbit model. , 2014, Biomaterials.

[74]  Ozgür Selek,et al.  Mesenchymal stem cell application improves tendon healing via anti-apoptotic effect (Animal study). , 2014, Acta orthopaedica et traumatologica turcica.

[75]  P. Lesný,et al.  Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat , 2014, Biomedical engineering online.

[76]  L. Schon,et al.  Stem Cell-Bearing Suture Improves Achilles Tendon Healing in a Rat Model , 2014, Foot & ankle international.

[77]  Mark R. Buckley,et al.  The Tendon Injury Response is Influenced by Decorin and Biglycan , 2014, Annals of Biomedical Engineering.

[78]  Allen E. Goodship,et al.  Beneficial Effects of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Naturally Occurring Tendinopathy , 2013, PloS one.

[79]  Roberta Perego,et al.  Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries. , 2013, Cytotherapy.

[80]  H. Langberg,et al.  Increased mast cell numbers in a calcaneal tendon overuse model , 2013, Scandinavian journal of medicine & science in sports.

[81]  Daniele Rossi,et al.  Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo. , 2013, Stem cells and development.

[82]  G. Murrell,et al.  Alarmins in tendinopathy: unravelling new mechanisms in a common disease. , 2013, Rheumatology.

[83]  P. Lui,et al.  Altered fate of tendon-derived stem cells isolated from a failed tendon-healing animal model of tendinopathy. , 2013, Stem cells and development.

[84]  A. Scott,et al.  Tendons – time to revisit inflammation , 2013, British Journal of Sports Medicine.

[85]  Marco Patruno,et al.  Effects of in vivo applications of peripheral blood‐derived mesenchymal stromal cells (PB‐MSCs) and platlet‐rich plasma (PRP) on experimentally injured deep digital flexor tendons of sheep , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[86]  P. Lui Identity of tendon stem cells – how much do we know? , 2012, Journal of cellular and molecular medicine.

[87]  P. Lui,et al.  Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. , 2012, Tissue engineering. Part A.

[88]  C. Pascual-Garrido,et al.  Treatment of Chronic Patellar Tendinopathy with Autologous Bone Marrow Stem Cells: A 5-Year-Followup , 2011, Stem cells international.

[89]  L. Hart Corticosteroid and other injections in the management of tendinopathies: a review. , 2011, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[90]  A. Scott,et al.  Substance P Is a Mechanoresponsive, Autocrine Regulator of Human Tenocyte Proliferation , 2011, PloS one.

[91]  M. Krampera,et al.  Mesenchymal stromal cell ‘licensing’: a multistep process , 2011, Leukemia.

[92]  Arnold I Caplan,et al.  The MSC: an injury drugstore. , 2011, Cell stem cell.

[93]  Lawrence V. Gulotta,et al.  Bone Marrow–Derived Mesenchymal Stem Cells Transduced With Scleraxis Improve Rotator Cuff Healing in a Rat Model , 2011, The American journal of sports medicine.

[94]  C. Recordati,et al.  Characterization and differentiation of equine tendon-derived progenitor cells. , 2011, Journal of biological regulators and homeostatic agents.

[95]  H. Mizuno,et al.  Differentiation of adipose-derived stem cells for tendon repair. , 2011, Methods in molecular biology.

[96]  S. Fu,et al.  Deciphering the pathogenesis of tendinopathy: a three-stages process , 2010, Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT.

[97]  Gang Li,et al.  Isolation and characterization of multipotent rat tendon-derived stem cells. , 2010, Tissue engineering. Part A.

[98]  J. Wang,et al.  Characterization of differential properties of rabbit tendon stem cells and tenocytes , 2010, BMC musculoskeletal disorders.

[99]  Lawrence V. Gulotta,et al.  Application of Bone Marrow-Derived Mesenchymal Stem Cells in a Rotator Cuff Repair Model , 2009, The American journal of sports medicine.

[100]  E. Geissler,et al.  Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function. , 2009, Transplantation proceedings.

[101]  M. Curtis,et al.  Treatment of lateral epicondylitis using skin-derived tenocyte-like cells , 2009, British Journal of Sports Medicine.

[102]  R. Bahr,et al.  Neuropeptides in tendinopathy. , 2009, Frontiers in bioscience.

[103]  G. Rossi,et al.  Cell therapy for tendinitis, experimental and clinical report , 2008, Veterinary Research Communications.

[104]  G. Murrell,et al.  Treatment of Tendinopathy: What Works, What Does Not, and What is on the Horizon , 2008, Clinical orthopaedics and related research.

[105]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[106]  Marian F Young,et al.  Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche , 2007, Nature Medicine.

[107]  Giovanni Battista Rossi,et al.  Cell Therapy for Tendon Repair in Horses: An Experimental Study , 2007, Veterinary Research Communications.

[108]  Beng Hai Lim,et al.  Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model. , 2007, The Journal of bone and joint surgery. American volume.

[109]  N. Maffulli,et al.  Biology of tendon injury: healing, modeling and remodeling. , 2006, Journal of musculoskeletal & neuronal interactions.

[110]  J. Yoon,et al.  Tendon proteoglycans: biochemistry and function. , 2005, Journal of musculoskeletal & neuronal interactions.

[111]  Pankaj Sharma,et al.  Tendon injury and tendinopathy: healing and repair. , 2005, The Journal of bone and joint surgery. American volume.

[112]  G. Riley,et al.  The pathogenesis of tendinopathy. A molecular perspective. , 2004, Rheumatology.

[113]  N Maffulli,et al.  Light Microscopic Histology of Achilles Tendon Ruptures , 2000, The American journal of sports medicine.

[114]  N Maffulli,et al.  Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin , 2000, British journal of sports medicine.

[115]  D L Butler,et al.  Autologous mesenchymal stem cell-mediated repair of tendon. , 1999, Tissue engineering.

[116]  A. Friedenstein,et al.  STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES: Cloning In Vitro and Retransplantation In Vivo , 1974, Transplantation.